A randomized, two-part registration study of the safety, tolerability, pharmacokinetics and antiviral activity of TXL in treatment-naïve HBV-infected subjects

Description: n/a

The Treat Asia HIV Observational Database (TAHOD)

This study collects observational data on HIV-infected patients from a number of sites in several Asian…

Bone health and vitamin D status in Thai HIV-1 infected and uninfected adults

This study will compare and assess the prevalence of osteopenia and vitamin D deficiency as well…

A long-term follow-up study for tuberculosis patients

This is a long-term cohort study of tuberculosis (TB) patients. This database will capture diagnosis of…

A phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of TMC278 in antiretroviral naive HIV-1 infected adolescents aged 12 to < 18 years

This is a Phase II, open-label (all people involved know the identity of the assigned drug)…

RTV GPO tablet study

This is pharmacokinetics, boosting efficacy and safety of GP-ritonavir tablets in HIV patients currently stable on…

Early ART to Limit Infection and Establishment of Reservoir (EARLIER)

This study will assess the effect of antiretroviral treatment initiated during acute HIV-1 infection on measures…

A phase II/III, multicenter, open-label, multicohort, two-part study evaluating Pharmacokinetics (PK), safety, and efficacy of cobicistat-boosted Atazanavir (ATV/co) or cobicistat-boosted Darunavir (DRV/co), administered with Background Regimen (BR) in HIV-1 infected, treatment-experienced, virologically suppressed pediatric subjects

This study will evaluate the steady-state pharmacokinetics (PK) and confirm the dose of cobicistat-boosted atazanavir (ATV/co)…

A randomized, double-blind phase IIIb study to evaluate the safety and efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate versus Ritonavir-boosted Atazanavir plus Emtricitabine/Tenofovir disoproxil fumarate in HIV-1 infected, antiretroviral treatment-naïve women

Randomized, double-blinded, multicenter, active-controlled study to evaluate the safety and efficacy of a regimen containing elvitegravir/cobicistat/emtricitabine/tenofovir…

Phase III clinical trial of ultra-course Rifapentine/Isoniazid for the prevention of active tuberculosis in HIV-infected individuals with latent tuberculosis infection

This study will compare rifapentine plus isoniazid daily for 4 weeks to a standard regimen of…